Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 7,413 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue specimen Clear all

Conditions: Gastric Fistula
Interventions: gastro-gastric fistula closure; Procedure
Lead sponsor: Legacy Health System; Other
Eligibility: 18 Years to 85 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cancer, Autoimmune Diseases
Interventions: Infectious Disease Labwork, Fertility-Based Labwork; Diagnostic Test
Lead sponsor: University of Pittsburgh; Other
Eligibility: Up to 39 Years · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2031
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Endometrial Carcinoma
Interventions: Biospecimen Collection, Questionnaire Administration; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Scottsdale, Arizona • Jacksonville, Florida

Conditions: Breast Neoplasms, Breast Diseases
Interventions: Not listed
Lead sponsor: Sysmex America, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Tucson, Arizona • Houston, Texas

Conditions: Synovial Sarcoma
Interventions: ipilimumab; Biological
Lead sponsor: Ludwig Institute for Cancer Research; Other
Eligibility: 10 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: New York, New York

Conditions: Hepatitis C
Interventions: Interleukin 28B genotype; Genetic
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Brain Concussion, Mild Traumatic Brain Injury
Interventions: Physical Therapy; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 13 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Orland Park, Illinois • Niagara Falls, New York

Conditions: Obesity, Non-Alcoholic Fatty Liver Disease
Interventions: Blood Draw, Stool collection, BodPod Measurement, Liver Ultrasound; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 5 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Type 1 Diabetes Mellitus, Hypoglycemia, Hypoglycemia Unawareness
Interventions: Islet transplantation; Biological
Lead sponsor: Rodolfo Alejandro; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma
Interventions: CTC isolocation and analysis; Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 4
States / cities: Basking Ridge, New Jersey • Commack, New York • Harrison, New York + 1 more

Conditions: Colon Adenoma, Colon Polyp, Colon Lesion
Interventions: Endoscopic tissue resection; Procedure
Lead sponsor: University of British Columbia; Other
Eligibility: 18 Years and older
Enrollment: 3,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Saint Cloud, Minnesota

Conditions: Cellular Diagnosis, Prostate Cancer
Interventions: ClariCore Optical Biopsy System; Device
Lead sponsor: Precision Biopsy, Inc.; Industry
Eligibility: 22 Years and older · Male only
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 6
States / cities: Denver, Colorado • Baltimore, Maryland • New York, New York + 2 more

Conditions: Imaged Breast Abnormalities
Interventions: Not listed
Lead sponsor: Intact Medical Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 24
States / cities: Little Rock, Arkansas • Indio, California • Long Beach, California + 20 more

Conditions: Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma, Skin Cancer
Interventions: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2; Biological · Drug
Lead sponsor: Karam Khaddour, MD, MS; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia
Interventions: Fludarabine, Fractionated total body irradiation, Busulfan, Cyclophosphamide, Single dose total body irradiation, Melphalan, Granulocyte-colony stimulating factor, Stem cell transplant, Azacitidine; Drug · Radiation · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Williams Syndrome, Cardiovascular Disease, Multisystem Developmental Disorder, Elastin Gene Deletion, Hypertension
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 1 Year to 70 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alopecia Areata, Scarring Alopecia
Interventions: tSVF by lipoaspiration, PRP Concentration, Emulsification tSVF, cSVF isolation and concentration, cSVF in Normal Saline IV; Procedure
Lead sponsor: Regeneris Medical; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 3
States / cities: Irvine, California • North Attleboro, Massachusetts • Stevensville, Montana

Conditions: Pregnancy of Unknown Location
Interventions: Hysteroscopy for diagnosis and treatment of pregnancy of unknown location; Diagnostic Test
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pelvic Floor Disorders
Interventions: Postmenopausal, topical vaginal estrogen cream, Placebo Comparator: Postmenopausal, topical placebo cream; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Osteoarthritis, Fibromyalgia
Interventions: NEM Formulation X, NEM Formulation Y; Dietary Supplement
Lead sponsor: ESM Technologies, LLC; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Jenks, Oklahoma

Conditions: Prostate Cancer
Interventions: bicalutamide, estramustine phosphate sodium, etoposide, flutamide, paclitaxel, Luteinizing hormone releasing hormone [LHRH] agonist, Radiation therapy, warfarin; Drug · Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2013
U.S. locations: 52
States / cities: Birmingham, Alabama • Phoenix, Arizona • Concord, California + 43 more

Conditions: Lung Neoplasms, Liver Neoplasms, Kidney Neoplasms, Cancer
Interventions: Needle angle measurement; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: ICU Acquired Weakness
Interventions: TetraGraph, Electromyography, Nerve conduction studies; Device
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Tobacco Use Disorder
Interventions: Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Zileuton; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 2
States / cities: Tucson, Arizona • Boston, Massachusetts

Search by objective public record fields.

Endoscopic Treatment of Intestinal Fistulas and Perforations

Ovarian Tissue Cryopreservation for Fertility Preservation

Targeting Inflammation for Endometrial Cancer Prevention

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B

The Role of Mechanical Diagnosis and Therapy in the Management of Concussion

Evaluation of Intestinal Microbiome in Obese Kids

Allogeneic Islet Cells Transplanted Onto the Omentum

Predicting Effective Therapy in Pancreatic Cancer

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

Percutaneous Excision Trial

TIL Therapy in cSCC and MCC

Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

Hysteroscopy for the Diagnosis and Treatment of Pregnancy of Unknown Location

Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse

Efficacy & Safety Study of Natural Eggshell Membrane (NEM) for the Treatment of Joint & Connective Tissue Disorders

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy

ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.

Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers